Approvals/TGA/RUBIFEN LA methylphenidate hydrochloride 10 mg modified release capsules blister pack

Approved

STANDARD

RUBIFEN LA methylphenidate hydrochloride 10 mg modified release capsules blister pack

AFT Pharmaceuticals Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 2de9231ee682f044
Product Name: RUBIFEN LA methylphenidate hydrochloride 10 mg modified release capsules blister pack
Artg Id: 362233
Artg Name: RUBIFEN LA methylphenidate hydrochloride 10 mg modified release capsules blister pack
Sponsor: AFT Pharmaceuticals Pty Ltd
Company Detail Path: /organization/aft-pharmaceuticals-au-pty-ltd
Artg Date: 2022-05-26
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2022-CMI-01474-1
Product Information: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2022-PI-01473-1

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

2de9231ee682f044

Type

Standard